Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro cannot be purchased through Klarna or any buy-now-pay-later platform in the UK. As a prescription-only medicine, it can only be supplied following a clinical assessment by a registered prescriber — and UK pharmacy regulations mean payment-splitting services like Klarna are not part of a legitimate Mounjaro transaction. If you have seen Mounjaro listed on a Klarna-linked site, that is a red flag worth taking seriously. The rest of this page explains why, and what a legal, clinician-reviewed route actually looks like.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception worth tackling head-on. Klarna is a legitimate payment processor used by thousands of legitimate retailers, clothing, electronics, homewares. The problem is not Klarna itself. The problem is what it signals when it appears alongside the sale of a prescription-only medicine.
In the UK, Mounjaro is a Prescription-Only Medicine under the Human Medicines Regulations 2012. That means it can only legally change hands after a prescriber has assessed a patient and issued a prescription. A GPhC-registered pharmacy then dispenses it. That chain (assessment, prescription, regulated dispensing) does not include a buy-now-pay-later checkout. When sellers bypass that chain and integrate consumer payment platforms instead, it usually means the prescription step has been skipped entirely.
The MHRA has been explicit about this pattern. Sellers operating outside the licensed supply chain have been found offering weight-loss medicines through social-media shops and informal payment links, sometimes with reported adverse events logged through the Yellow Card scheme after patients received unknown substances. The medicine in those pens is not guaranteed to be tirzepatide at all. Some seized counterfeits have contained insulin, a dangerous substitution.
So the myth is that Klarna in a Mounjaro listing is a neutral detail. It is not. It is a reliable indicator that something in that transaction falls outside the legal and clinical framework that keeps people safe.
Sellers who advertise Mounjaro on Klarna in the UK fall into a small number of categories, none of them reassuring. Some are operating as unregistered suppliers, sourcing pens through grey-market or outright counterfeit channels and using consumer-friendly payment tools to appear credible. Others are registered in name but are sidestepping the mandatory clinical-assessment process, accepting payment before any prescriber has reviewed the patient.
In October 2025, the MHRA raided the first illicit UK manufacturing site producing counterfeit tirzepatide pens, in Northampton. The scale of enforcement (roughly £45m worth of illegally traded weight-loss medicines seized across 2025 alone) makes clear this is not a fringe concern. These products can look convincing. The packaging may be close to authentic. The pen may even feel familiar. If you have come across products sold as alterna tirzepatide, it is worth reading what that term actually covers before drawing any conclusions about legitimacy. But without a verified, licensed supply chain, there is no way to know what is inside it.
The cost argument is often what draws people to these listings. If you are researching what Mounjaro treatment actually involves and comparing prices across providers, it is worth understanding that any headline price offering Mounjaro cheaply through an informal payment service has, by definition, removed the clinical costs, because the clinical step has been removed too.
One thing our prescribers hear fairly often: patients who bought from an unverified source had no idea whether they were getting the right dose, a real product, or anything close to what they thought they were injecting. That uncertainty is not a minor inconvenience.
A registered online pharmacy in the UK does not offer Mounjaro like a standard e-commerce product. The sequence goes the other way around: clinical assessment first, then prescription, then dispensing, then payment, and only if the prescriber determines treatment is appropriate.
At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber on the same day it is submitted. Identity is verified with a photo ID check, and weight is confirmed live on video, not taken on trust from a form. Consultations are free. So is the prescription, delivery, and aftercare. Once a prescriber approves treatment, orders placed before 12pm on a working day are dispatched the same day and arrive the next working day via DPD, tracked, in plain packaging. No subscription, no auto-renewal, no hidden fees.
If you want to verify any online pharmacy before using it, the GPhC register is the right place to start. You can check our registration directly at GPhC premises registration 9012878. Any pharmacy that cannot point you to a GPhC listing should not be dispensing prescription medicines.
For a broader look at what to consider when accessing weight-loss treatment privately, our treatment overview covers the full picture, including what the clinical assessment involves and what happens after your first prescription.
If the Klarna search is really a cost search (an attempt to spread the expense of treatment across monthly instalments) that is a completely understandable thing to look for. Mounjaro is not cheap. Following Eli Lilly's UK list-price increase in September 2025, typical private prices for Mounjaro in the UK have ranged from roughly £149 to £375 per month depending on dose and provider, as widely reported.
For more context on how those figures break down and what they typically do and do not include, our page on Mounjaro pricing and payment is the practical next read. The short version: legitimate providers generally include the clinical consultation, the prescription, and delivery in a single price. Providers who appear cheaper often unbundle those components, or skip them.
It is also worth knowing that tirzepatide's licensed use in the UK requires ongoing clinical oversight. The starting dose, the titration schedule, the decision to continue or pause, these are prescriber decisions, made review by review. If you are currently on or considering Mounjaro 2, those titration decisions are particularly important to discuss with a prescriber before making any changes. A one-off purchase through a payment platform does not give you that. For a prescription medicine, the ongoing clinical relationship is part of what you are paying for. It is not an optional extra.
If you would like a proper assessment and a clear, all-in price with no surprises, start your free consultation and a prescriber will review your details the same day. Patients sometimes also ask whether Mounjaro contains mRNA, and that page sets out a clear, evidence-based answer if that question is on your mind.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.